what's better semaglutide or tripeptide vs. Tirzepatide: Which Is the Best at Managing Weight Loss? Tirzepatide vs Semaglutide: What's the

While semaglutide is a powerful medication for treating certain conditions, like type 2 diabetes and obesity, it can also bring about a range of side effects

Louisiana Patients Could Lose Access to GLP-1 Weight-Loss Drugs as Coverage Vanishes Highlights Louisiana state employees are already prohibited from using GLP-1s for weight loss despite $200 million annual spending on diabetes coverage Over 41 million Americans lost commercial insurance coverage for Wegovy in 2026, with major insurers eliminating coverage nationwide Four states, including California and Pennsylvania, eliminated Medicaid coverage for obesity treatment between October 2025 and January 2026 Louisiana Medicaid provides limited coverage for one non-GLP-1 weight-loss drug but restrictions remain tight Patients face monthly costs ranging from $936 to $1,349 without insurance coverage BATON ROUGE, La

If you experience severe, persistent abdominal pain while taking a GLP-1 receptor agonist, seek urgent medical attention

Pothof, R.W.F